Q3 2016

Filed Nov 10, 2016 · 10-Q · 41 days after period end · 0001144204-16-133328

Q3 2016 · 10-Q

Revenue

$159.00K

−45.4% vs Q3 2015

Net Income

-$29.23M

N/M vs Q3 2015

EPS Diluted

-$0.28

N/M vs Q3 2015

Operating Income-$25,516,000N/M

Operating Cash Flow

Same quarter

Metric	Q3 2016	Q3 2015	Q3 2014	Q3 2013
Revenue	$159.00K	$291.00K	$582.00K	$400.00K
Net Income	-$29.23M	$22.62M	-$21.04M	-$22.91M
EPS Diluted	-$0.28	$0.25	-$0.35	-$0.65

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Northwest Biotherapeutics Inc · CIK 1072379 · Engraved from SEC EDGAR